DVAX
Price
$14.09
Change
+$0.45 (+3.30%)
Updated
Sep 25, 6:59 PM EST
44 days until earnings call
TAK
Price
$15.96
Change
+$0.12 (+0.76%)
Updated
Sep 25, 12:04 PM EST
31 days until earnings call

Analysis and predictions DVAX vs TAK

Header iconDVAX vs TAK Comparison
Open Charts DVAX vs TAKBanner chart's image
Dynavax Technologies
Price$14.09
Change+$0.45 (+3.30%)
Volume$785.68K
CapitalizationN/A
Takeda Pharmaceutical
Price$15.96
Change+$0.12 (+0.76%)
Volume$796
CapitalizationN/A
View a ticker or compare two or three
DVAX vs TAK Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
DVAX vs. TAK commentary
Sep 25, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DVAX is a Hold and TAK is a Sell.

COMPARISON
Comparison
Sep 25, 2023
Stock price -- (DVAX: $13.64 vs. TAK: $15.84)
Brand notoriety: DVAX and TAK are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: DVAX: 62% vs. TAK: 60%
Market capitalization -- DVAX: $1.76B vs. TAK: $49.6B
DVAX [@Pharmaceuticals: Other] is valued at $1.76B. TAK’s [@Pharmaceuticals: Other] market capitalization is $49.6B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $81.33B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $2.59B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DVAX’s FA Score shows that 1 FA rating(s) are green whileTAK’s FA Score has 1 green FA rating(s).

  • DVAX’s FA Score: 1 green, 4 red.
  • TAK’s FA Score: 1 green, 4 red.
According to our system of comparison, DVAX is a better buy in the long-term than TAK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DVAX’s TA Score shows that 5 TA indicator(s) are bullish while TAK’s TA Score has 6 bullish TA indicator(s).

  • DVAX’s TA Score: 5 bullish, 5 bearish.
  • TAK’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, TAK is a better buy in the short-term than DVAX.

Price Growth

DVAX (@Pharmaceuticals: Other) experienced а -0.07% price change this week, while TAK (@Pharmaceuticals: Other) price change was -2.94% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +3.13%. For the same industry, the average monthly price growth was +18.58%, and the average quarterly price growth was +10.13%.

Reported Earning Dates

DVAX is expected to report earnings on Nov 08, 2023.

TAK is expected to report earnings on Oct 26, 2023.

Industries' Descriptions

@Pharmaceuticals: Other (+3.13% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
A.I.dvisor published
a Summary for DVAX with price predictions.
OPEN
A.I.dvisor published
a Summary for TAK with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
TAK($49.6B) has a higher market cap than DVAX($1.76B). TAK has higher P/E ratio than DVAX: TAK (24.57) vs DVAX (18.69). DVAX YTD gains are higher at: 28.195 vs. TAK (1.538). TAK has higher annual earnings (EBITDA): 1.15T vs. DVAX (126M). TAK has more cash in the bank: 369B vs. DVAX (682M). DVAX has less debt than TAK: DVAX (258M) vs TAK (4.75T). TAK has higher revenues than DVAX: TAK (4.11T) vs DVAX (459M).
DVAXTAKDVAX / TAK
Capitalization1.76B49.6B4%
EBITDA126M1.15T0%
Gain YTD28.1951.5381,833%
P/E Ratio18.6924.5776%
Revenue459M4.11T0%
Total Cash682M369B0%
Total Debt258M4.75T0%
FUNDAMENTALS RATINGS
DVAX vs TAK: Fundamental Ratings
DVAX
TAK
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
65
Fair valued
19
Undervalued
PROFIT vs RISK RATING
1..100
93100
SMR RATING
1..100
4443
PRICE GROWTH RATING
1..100
4348
P/E GROWTH RATING
1..100
875
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TAK's Valuation (19) in the Pharmaceuticals Major industry is somewhat better than the same rating for DVAX (65) in the Biotechnology industry. This means that TAK’s stock grew somewhat faster than DVAX’s over the last 12 months.

DVAX's Profit vs Risk Rating (93) in the Biotechnology industry is in the same range as TAK (100) in the Pharmaceuticals Major industry. This means that DVAX’s stock grew similarly to TAK’s over the last 12 months.

TAK's SMR Rating (43) in the Pharmaceuticals Major industry is in the same range as DVAX (44) in the Biotechnology industry. This means that TAK’s stock grew similarly to DVAX’s over the last 12 months.

DVAX's Price Growth Rating (43) in the Biotechnology industry is in the same range as TAK (48) in the Pharmaceuticals Major industry. This means that DVAX’s stock grew similarly to TAK’s over the last 12 months.

DVAX's P/E Growth Rating (8) in the Biotechnology industry is significantly better than the same rating for TAK (75) in the Pharmaceuticals Major industry. This means that DVAX’s stock grew significantly faster than TAK’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DVAXTAK
RSI
ODDS (%)
Bullish Trend 4 days ago
89%
Bearish Trend 4 days ago
42%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 4 days ago
51%
Momentum
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 4 days ago
42%
MACD
ODDS (%)
Bearish Trend 4 days ago
79%
Bullish Trend 4 days ago
51%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
82%
Bearish Trend 4 days ago
51%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
81%
Bullish Trend 4 days ago
43%
Advances
ODDS (%)
Bullish Trend 12 days ago
84%
Bullish Trend 11 days ago
47%
Declines
ODDS (%)
Bearish Trend 8 days ago
84%
Bearish Trend 4 days ago
45%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
86%
Bearish Trend 4 days ago
47%
Aroon
ODDS (%)
Bearish Trend 4 days ago
78%
Bullish Trend 4 days ago
45%
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CAFCX28.22-0.04
-0.14%
American Funds AMCAP 529C
TICSX5.74-0.01
-0.17%
Touchstone Small Company Instl
CBMSX38.94-0.11
-0.28%
Allspring C&B Mid Cap Value Inst
MGISX32.56-0.10
-0.31%
Morgan Stanley Inst Global Franchise R6
TRGRX15.33-0.08
-0.52%
T. Rowe Price Global Real Estate

DVAX and

Correlation & Price change

A.I.dvisor indicates that over the last year, DVAX has been loosely correlated with SIGA. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if DVAX jumps, then SIGA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DVAX
1D Price
Change %
DVAX100%
-0.66%
SIGA - DVAX
48%
Loosely correlated
+0.64%
ELAN - DVAX
43%
Loosely correlated
-0.71%
ZTS - DVAX
42%
Loosely correlated
+0.03%
ACET - DVAX
39%
Loosely correlated
-4.58%
IRWD - DVAX
38%
Loosely correlated
-1.28%
More

TAK and

Correlation & Price change

A.I.dvisor indicates that over the last year, TAK has been loosely correlated with RDY. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if TAK jumps, then RDY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TAK
1D Price
Change %
TAK100%
-0.56%
RDY - TAK
39%
Loosely correlated
-2.08%
DVAX - TAK
31%
Poorly correlated
-0.66%
EVO - TAK
31%
Poorly correlated
+1.37%
PBH - TAK
30%
Poorly correlated
+0.85%
HLN - TAK
28%
Poorly correlated
-1.93%
More